About the agency
Ruder Finn is a New York-founded global communications and marketing agency established in 1948 by David Finn and Bill Ruder. Its original practice grew from corporate and organizational publicity into an international firm specializing in healthcare, technology, consumer brands and stakeholder relations. Kathy Bloomgarden leads the business as CEO, with regional and sector teams serving complex corporate and public-facing communications programs.
The agency handles strategic media relations, executive storytelling, scientific and healthcare communications, corporate reputation, technology positioning, brand experience and public affairs. Its healthcare teams work with treatment developments, regulatory milestones, clinician engagement and patient education, while its technology teams address enterprise innovation and AI. Ruder Finn has also built in-house AI tools for communications research, content and visibility measurement.
Recent agency announcements include Wendy's selection of Ruder Finn as a North American communications partner in July 2026, a new global health and life-sciences leader in May, and the March 2026 acquisition of investor relations specialist The Equity Group. Its past client announcements include healthcare and corporate work involving Teva Pharmaceuticals, GSK and Nestlé Health Science. These programs show both a longstanding media-relations practice and an expanding set of specialist services.